CYP2C19 and CYP2D6 genotypes in Pacific peoples
- PMID: 27304207
- PMCID: PMC5061802
- DOI: 10.1111/bcp.13045
CYP2C19 and CYP2D6 genotypes in Pacific peoples
Abstract
The study of pharmacogenetic variants in populations which reside in Oceania has been focused mainly on CYP2C19 and CYP2D6. Statements about the high prevalence of CYP2C19 no function genotype in 'Pacific Islanders' can be found in the literature. This review article summarizes the published information about these pharmacogenes in this geographical region and highlights the differences observed between Melanesian and Polynesian populations. It is not appropriate to combine the prevalence data of pharmacogenetic variants, particularly CYP2C19, across this region. Indeed, apocryphal assumptions about CYP2C19 no function alleles and possible effect on the therapeutic activity of clopidogrel are unhelpful and reiterate the importance of assessing the individual patient rather than relying on inappropriate ethnicity-based assumptions for drug dosing decisions.
Keywords: CYP2C19; CYP2D6; Ethnicity; Pharmacogenetics.
© 2016 The British Pharmacological Society.
References
-
- Veeramah KR, Hammer MF. The impact of whole‐genome sequencing on the reconstruction of human population history. Nat Rev Genet 2014; 15: 149–162. - PubMed
-
- Wollstein A, Lao O, Becker C, Brauer S, Trent RJ, Nürnberg P, et al. Demographic history of Oceania inferred from genome‐wide data. Curr Biol 2010; 20: 1983–1992. - PubMed
-
- Fricke‐Galindo I, Céspedes‐Garro C, Rodrigues‐Soares F, Naranjo MEG, Delgado Á, de Andrés F, et al. Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations. Pharmacogenomics J 2015; 16: 113–123. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
